Can a Single Stain Transform Bone Tumor Diagnosis in a Value-Based World?
Exploring the Clinical Impact and Reimbursement Value of H3G34W Immunostaining in the Era of Precision Pathology
Healthcare Chronicle by Dr. Adam Tabriz
The modern healthcare environment demands rapid precise cost-efficient pathology diagnostic services as precision medicine adopts value-based reimbursement (VBR) standards. Giant cell tumor of bone (GCTB) is difficult to detect in orthopedic oncology because it share…
